Drug-Induced Mitochondrial Cardiomyopathy and Cardiovascular Risks in Children

Neha Bansal, Mariana Gerschenson, Tracie L Miller, Stephen E. Sallan, Jason Czachor, Hiedy Razoky, Ashley Hill, Miriam Mestre, Steven E Lipshultz

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter describes the mechanisms and the short- and long-term consequences of human immunodeficiency virus (HIV) medications and cancer chemotherapies that are associated with mitochondrial dysfunction and its cardiac consequences in children. Adults and children with HIV are living longer because of advances in antiretroviral therapy (ART). Mitochondrial dysfunction secondary to ART is drug and organ specific. This specificity was first described in 1988, in HIV patients treated with high doses of the nucleoside reverse transcriptase inhibitor (NRTI), zidovudine. One of the major successes of pediatric oncology is that children with childhood cancers are living substantially longer and healthier lives because of advances in chemotherapeutic agents. Chemotherapeutic medications are designed to interfere with rapidly dividing neoplastic cells. However, in the process, they can adversely affect normal cell division, especially in tissues with rapid turnover.

Original languageEnglish (US)
Title of host publicationMitochondrial Dysfunction Caused by Drugs and Environmental Toxicants
Publisherwiley
Pages529-546
Number of pages18
Volume2-2
ISBN (Electronic)9781119329725
ISBN (Print)9781119329701
DOIs
StatePublished - Feb 21 2018

Fingerprint

Cardiomyopathies
Viruses
HIV
Pharmaceutical Preparations
Drug therapy
Drug Therapy
Pediatrics
Reverse Transcriptase Inhibitors
Oncology
Chemotherapy
Zidovudine
Nucleosides
Cell Division
Neoplasms
Cells
Tissue
Therapeutics

Keywords

  • Antiretroviral therapy
  • Cardiac consequences
  • Chemotherapeutic medications
  • Human immunodeficiency virus
  • Mitochondrial cardiomyopathy
  • NRTI
  • Pediatric oncology

ASJC Scopus subject areas

  • Chemistry(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Bansal, N., Gerschenson, M., Miller, T. L., Sallan, S. E., Czachor, J., Razoky, H., ... Lipshultz, S. E. (2018). Drug-Induced Mitochondrial Cardiomyopathy and Cardiovascular Risks in Children. In Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants (Vol. 2-2, pp. 529-546). wiley. https://doi.org/10.1002/9781119329725.ch35

Drug-Induced Mitochondrial Cardiomyopathy and Cardiovascular Risks in Children. / Bansal, Neha; Gerschenson, Mariana; Miller, Tracie L; Sallan, Stephen E.; Czachor, Jason; Razoky, Hiedy; Hill, Ashley; Mestre, Miriam; Lipshultz, Steven E.

Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants. Vol. 2-2 wiley, 2018. p. 529-546.

Research output: Chapter in Book/Report/Conference proceedingChapter

Bansal, N, Gerschenson, M, Miller, TL, Sallan, SE, Czachor, J, Razoky, H, Hill, A, Mestre, M & Lipshultz, SE 2018, Drug-Induced Mitochondrial Cardiomyopathy and Cardiovascular Risks in Children. in Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants. vol. 2-2, wiley, pp. 529-546. https://doi.org/10.1002/9781119329725.ch35
Bansal N, Gerschenson M, Miller TL, Sallan SE, Czachor J, Razoky H et al. Drug-Induced Mitochondrial Cardiomyopathy and Cardiovascular Risks in Children. In Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants. Vol. 2-2. wiley. 2018. p. 529-546 https://doi.org/10.1002/9781119329725.ch35
Bansal, Neha ; Gerschenson, Mariana ; Miller, Tracie L ; Sallan, Stephen E. ; Czachor, Jason ; Razoky, Hiedy ; Hill, Ashley ; Mestre, Miriam ; Lipshultz, Steven E. / Drug-Induced Mitochondrial Cardiomyopathy and Cardiovascular Risks in Children. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants. Vol. 2-2 wiley, 2018. pp. 529-546
@inbook{1c014485f0ba4dd4912c5cf22c24dae6,
title = "Drug-Induced Mitochondrial Cardiomyopathy and Cardiovascular Risks in Children",
abstract = "This chapter describes the mechanisms and the short- and long-term consequences of human immunodeficiency virus (HIV) medications and cancer chemotherapies that are associated with mitochondrial dysfunction and its cardiac consequences in children. Adults and children with HIV are living longer because of advances in antiretroviral therapy (ART). Mitochondrial dysfunction secondary to ART is drug and organ specific. This specificity was first described in 1988, in HIV patients treated with high doses of the nucleoside reverse transcriptase inhibitor (NRTI), zidovudine. One of the major successes of pediatric oncology is that children with childhood cancers are living substantially longer and healthier lives because of advances in chemotherapeutic agents. Chemotherapeutic medications are designed to interfere with rapidly dividing neoplastic cells. However, in the process, they can adversely affect normal cell division, especially in tissues with rapid turnover.",
keywords = "Antiretroviral therapy, Cardiac consequences, Chemotherapeutic medications, Human immunodeficiency virus, Mitochondrial cardiomyopathy, NRTI, Pediatric oncology",
author = "Neha Bansal and Mariana Gerschenson and Miller, {Tracie L} and Sallan, {Stephen E.} and Jason Czachor and Hiedy Razoky and Ashley Hill and Miriam Mestre and Lipshultz, {Steven E}",
year = "2018",
month = "2",
day = "21",
doi = "10.1002/9781119329725.ch35",
language = "English (US)",
isbn = "9781119329701",
volume = "2-2",
pages = "529--546",
booktitle = "Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants",
publisher = "wiley",

}

TY - CHAP

T1 - Drug-Induced Mitochondrial Cardiomyopathy and Cardiovascular Risks in Children

AU - Bansal, Neha

AU - Gerschenson, Mariana

AU - Miller, Tracie L

AU - Sallan, Stephen E.

AU - Czachor, Jason

AU - Razoky, Hiedy

AU - Hill, Ashley

AU - Mestre, Miriam

AU - Lipshultz, Steven E

PY - 2018/2/21

Y1 - 2018/2/21

N2 - This chapter describes the mechanisms and the short- and long-term consequences of human immunodeficiency virus (HIV) medications and cancer chemotherapies that are associated with mitochondrial dysfunction and its cardiac consequences in children. Adults and children with HIV are living longer because of advances in antiretroviral therapy (ART). Mitochondrial dysfunction secondary to ART is drug and organ specific. This specificity was first described in 1988, in HIV patients treated with high doses of the nucleoside reverse transcriptase inhibitor (NRTI), zidovudine. One of the major successes of pediatric oncology is that children with childhood cancers are living substantially longer and healthier lives because of advances in chemotherapeutic agents. Chemotherapeutic medications are designed to interfere with rapidly dividing neoplastic cells. However, in the process, they can adversely affect normal cell division, especially in tissues with rapid turnover.

AB - This chapter describes the mechanisms and the short- and long-term consequences of human immunodeficiency virus (HIV) medications and cancer chemotherapies that are associated with mitochondrial dysfunction and its cardiac consequences in children. Adults and children with HIV are living longer because of advances in antiretroviral therapy (ART). Mitochondrial dysfunction secondary to ART is drug and organ specific. This specificity was first described in 1988, in HIV patients treated with high doses of the nucleoside reverse transcriptase inhibitor (NRTI), zidovudine. One of the major successes of pediatric oncology is that children with childhood cancers are living substantially longer and healthier lives because of advances in chemotherapeutic agents. Chemotherapeutic medications are designed to interfere with rapidly dividing neoplastic cells. However, in the process, they can adversely affect normal cell division, especially in tissues with rapid turnover.

KW - Antiretroviral therapy

KW - Cardiac consequences

KW - Chemotherapeutic medications

KW - Human immunodeficiency virus

KW - Mitochondrial cardiomyopathy

KW - NRTI

KW - Pediatric oncology

UR - http://www.scopus.com/inward/record.url?scp=85050901624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050901624&partnerID=8YFLogxK

U2 - 10.1002/9781119329725.ch35

DO - 10.1002/9781119329725.ch35

M3 - Chapter

SN - 9781119329701

VL - 2-2

SP - 529

EP - 546

BT - Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants

PB - wiley

ER -